ProShare Advisors’s AC Immune ACIU Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q1 | – | Sell |
-11,230
| Closed | -$56K | – | 2196 |
|
2021
Q4 | $56K | Sell |
11,230
-5,806
| -34% | -$29K | ﹤0.01% | 2273 |
|
2021
Q3 | $114K | Buy |
17,036
+3,983
| +31% | +$26.7K | ﹤0.01% | 1895 |
|
2021
Q2 | $104K | Buy |
+13,053
| New | +$104K | ﹤0.01% | 2286 |
|
2021
Q1 | – | Sell |
-11,072
| Closed | -$57K | – | 2258 |
|
2020
Q4 | $57K | Sell |
11,072
-508
| -4% | -$2.62K | ﹤0.01% | 2037 |
|
2020
Q3 | $57K | Buy |
11,580
+98
| +0.9% | +$482 | ﹤0.01% | 1583 |
|
2020
Q2 | $77K | Buy |
+11,482
| New | +$77K | ﹤0.01% | 1599 |
|
2020
Q1 | – | Sell |
-14,611
| Closed | -$124K | – | 1163 |
|
2019
Q4 | $124K | Sell |
14,611
-3,679
| -20% | -$31.2K | ﹤0.01% | 1668 |
|
2019
Q3 | $91K | Sell |
18,290
-1,428
| -7% | -$7.11K | ﹤0.01% | 1561 |
|
2019
Q2 | $109K | Sell |
19,718
-3,197
| -14% | -$17.7K | ﹤0.01% | 1522 |
|
2019
Q1 | $116K | Buy |
22,915
+3,473
| +18% | +$17.6K | ﹤0.01% | 1556 |
|
2018
Q4 | $184K | Buy |
+19,442
| New | +$184K | ﹤0.01% | 1390 |
|